FARMACOCINÉTICA EXPERIMENTAL Y CLÍNICA
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (9)
2024
-
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry
Therapeutic Advances in Gastroenterology, Vol. 17
2023
-
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247
-
Splanchnic Vein Thrombosis in Inflammatory Bowel Disease: An Observational Study from the ENEIDA Registry and Systematic Review
Journal of Clinical Medicine, Vol. 12, Núm. 23
2019
-
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
Journal of Crohn's & colitis, Vol. 13, Núm. 12, pp. 1492-1500
2011
-
Levofloxacin weight-adjusted dosing and pharmacokinetic disposition in a morbidly obese patient
Journal of Antimicrobial Chemotherapy
2007
-
Impacto de la EPOC en la vida diaria de los pacientes. Resultados del estudio multicéntrico EIME
Archivos de Bronconeumologia, Vol. 43, Núm. 2, pp. 64-72
-
Pharmacokinetic/pharmacodynamic indices: Are we ready to use them in daily practice?
Expert Review of Anti-Infective Therapy
2006
-
Exacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary disease
Quality of Life Research, Vol. 15, Núm. 3, pp. 471-480
2005
-
Pharmacokinetics and pharmacodynamics of levofloxacin in intensive care patients
Clinical Pharmacokinetics, Vol. 44, Núm. 6, pp. 627-635